Neurologic - Biogen

Neurologic

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05798520

A 2-Part, Multicenter, Randomized, Blinded, Active-Controlled Phase 2 Study to Sequentially Evaluate the Safety and Efficacy of BIIB091 Monotherapy and BIIB091 Combination Therapy With Diroximel Fumarate in Participants With Relapsing Forms of Multiple Sclerosis

Device

BIIB091 Monotherapy and BIIB091 Combination

Phase

Phase II

Condition

Relapsing Forms of Multiple Sclerosis, RMS, MS

Keywords

Relapsing Forms of Multiple Sclerosis | RMS | MS